Breaking News

Almac Invests in NMR Technology to Enhance Analytical Services

High-res NMR is a key enabling technology that delivers advanced characterization and purity assessment abilities in line with regulatory requirements.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Almac Sciences, a member of the Almac Group, is investing £500,000 in NMR instrumentation at its global Headquarters, Craigavon, UK, marking an over £900,000 total investment in nuclear magnetic resonance (NMR) technology for the organization since 2018.   High-resolution NMR is a key enabling technology that delivers advanced characterization and purity assessment abilities in line with regulatory requirements. The service helps support drug substance (API) and drug product development progra...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters